The downregulation of this Vav1-dependent pathway, via transcriptional repression of the VAV1 rather than loss-of-function mutations, seems to represent a key contributing factor in the pathogenesis of human TLX+ T-ALL. The gene discussed is VAV1; the disease is acute lymphoblastic leukemia.